Actions and Detail Panel
Biomanufacturing Global Congress 2017 Europe
Mon, 3 Apr 2017, 08:00 – Tue, 4 Apr 2017, 17:30 BST
Over the past decade, biomanufacturing has become a strategic driver to scalable and flexible operations, controlled costs, and high quality drug market access. The advances in manufacturing technologies--in particular continuous manufacturing, process analytical technology, single-use systems, alternative down processing techniques and drug device systems--continue to influence the biopharmaceutical workforce, impacting the manufacturers’ collaboration strategies and their choices of facility locations.
In the upcoming BIOMANUFACTURING GLOBAL CONGRESS 2017 EUROPE, a more reactive and dynamic approach to key trends, methodologies and insights on manufacturing, supply chain, quality management and compliance than the current industry standard is anticipated.